Background: To date, the measurement of the orocaecal transit time (OCTT) with lactose-[
Introduction
Within the last decade the non-invasive lactose-[
13 C]ureide ( 13 C-LU) breath test for measuring the orocaecal transit time (OCTT) has been re-established and is meanwhile generally accepted and applied by a broad number of scientific teams (Leitzmann et al., 1998; Geypens et al., 1999; Morrison et al., 1999; Van den Driessche et al., 2000; Christian et al., 2002; Priebe et al., 2004; Wutzke and Sattinger, 2006; Berthold et al., 2009) . The molecular bond between the sugar moieties and [ has been shown to approach the caecum undigested, but then to be split by Clostridium innocuum (Mohr et al., 1999) . In our previous studies, 13 C-LU, glucose-[ yield reliable results when pre-dosing with the analogous unlabelled ureides, lactose ureide (LU), glucose ureide (GU) and cellobiose ureide (CU), respectively (Wutzke et al., 1997; Wutzke and Glasenapp, 2004) . Furthermore, it could be demonstrated that the induced enzyme activity is short-lived and no longer exists after 1 week (Wutzke and Schütt, 2007) . Therefore, a pre-treatment with LU on the day before 13 C-LU ingestion is essential for OCTT measurements. However, Morrison et al. (2003) described the pre-dosing with GU before 13 C-LU ingestion but without measuring the faecal 13 C-excretion. In recently published papers, assessing the effects of pro-and prebiotics on the intestinal ammonia metabolism in humans when using lactose- 
Study protocols
Subjects were studied after an overnight fast. All volunteers received a continental breakfast made up of 1 wheat flour roll, 30 g butter, 1 slice of cheese, 25 g jam and 300 ml of black tea at 0745 hours. Six hours after breakfast, all volunteers received an individually standardized regular lunch at 1400 hours. Every single subject was allowed to choose his personal lunch menu but it was similar during the three tests (two fried eggs, sunny side up and two slices of wholemeal bread). Furthermore, the breakfast was identical in all 13 subjects on the days of DLLU administration. No other food or drink was allowed until 6 h after breakfast. Baseline breath, urine and faeces samples were collected 15, 30 and 60 min, respectively, before the ingestion of DLLU to determine the baseline abundance of 13 C and 15 N. During breakfast, 500 mg DLLU, corresponding to a 13 C-and 15 N-excess dose of 14.42 and 3.67 mg, respectively, was administered as a single oral pulse strewn on a small area of the butter at 0800 hours to ingest the label with one bite. Two expired breath samples were taken in 30-min intervals over a period of 14 h by direct exhalation into Exetainers (IVA Analysentechnik, Meerbusch, Germany). The urine was collected quantitatively in 2-, 4-and 6-h intervals over 48 h, whereas faeces were collected quantitatively over 72 h.
After a 1-week wash out period, the subjects received a predosage of 3 Â 120 mg GU in 4-h intervals (at 1200, 1600 and 2000 hours) 1 day before the repeated DLLU administration. After a further 1-week wash out period, the subjects repeated the test with pre-dosing of 3 Â 200 mg CU (equimolar to the GU dosage). The procedure of food intake, pre-dosing, DLLU administration, breath, urine and faeces collection was identical in all three tests.
Analytical techniques
Isotope ratio mass spectrometry. The 13 C-enrichment in breath was measured by isotope ratio mass spectrometry (Tracer mass 20-20, SerCon, Crewe, UK) as detailed previously (Barrie et al., 1989; Wutzke et al., 1997) . The data were expressed either as d Orocaecal transit time. The OCTT was calculated from the interval between DLLU intake and the detection of a significant, sustained and non-reversing increase of 13 CO 2 in breath of 2 DOB or more (Wutzke et al., 1997) .
Statistical analysis
The Kruskal-Wallis test and the Mann-Whitney U-test, on program SPSS 15.0 for Windows (Chicago, IL, USA) were used for statistical analysis. All results are quoted as means ± s.d.
Results
13 CO 2 signals were observed in the expired air of all subjects beginning 6.0 h after DLLU administration without predosing. The mean maximum 13 CO 2 -enrichment of 6.2 ± 4.1 DOB was reached after 14.0 h (Figure 1 ). The pre-dosing of GU and CU 1 day before the DLLU ingestion caused a shifting of the 13 CO 2 increase beginning after 4.5 h (maximum enrichment 7.0 ± 6.8 DOB at 6.0 h; and 8.8 ± 6.5 DOB at 7.5 h, respectively, Figure 1 ). In contrast to the delayed OCTT of 7.8 ± 2.2 h measured without pre-dosing, the increase of 13 CO 2 -enrichment after pre-dosing with both GU and CU was faster (B2 DOB/h) and led to a definitive estimation of the mean OCTT of 5.8±1.9 and 6.0±2.2 h, respectively, when using a threshold of 2 DOB (Table 1) . The observed OCTT differed significantly from the data without pre-dosing (P ¼ 0.033 and 0.039, respectively), whereas the data of the pre-dosing tests were not significantly different (Table 1) . The respective CPDR amounted to 17.7±8.4, 28.7±9.2 and 26.1±10.8%, respectively, and differed significantly from the data without pre-dosing (P ¼ 0.014 and 0.035, respectively), whereas the values of the pre-dosing tests were not significantly different (Table 1 , Figure 2 ). The respective renal 13 C-and 15 N-CPE amounted to 24.5 ± 7.9 and 45.6 ± 9.6, 24.7 ± 6.7 and 54.0 ± 10.5, and 22.5 ± 4.6 and 50.1 ± 14.6%, respectively, whereas the faecal 13 C-and 15 N-CPE amounted to 12.1±11.7 and 45.8±14.3, 4.8 ± 3.4 and 21.5 ± 15.9, and 9.6 ± 6.4 and 39.8 ± 24.5%, respectively (Table 2, Figure 2 ). The calculated data of the N-CPE were not significantly different, whereas significantly different numbers of the faecal 13 C-and 15 N-CPE were observed without-vs GU-(P ¼ 0.026), GU-vs CU-(P ¼ 0.006), and without-vs GU-pre-dosing (P ¼ 0.002), respectively. After administration of DLLU without and pre-dosing with GU and CU, the total 13 C-elimination in breath, urine and faeces after the time span of 14, 48 and 72 h, respectively, amounted to 56.9% on average in all three tests (54.3, 58.2 and 58.2%, respectively), whereas the corresponding 15 N-excretion in all three tests was found to be 85.6% on average (91.4, 75.5 and 89.9%, respectively, Figure 2 ).
Discussion
Since the primary publication in 1995, 13 CO 2 -breath tests for measuring the OCTT preferentially by using , 1998 , 2003 Wutzke and Sattinger, 2006; Schneider et al., 2007; Berthold et al., 2009) . It is commonly assumed that 13 C-GU and the corresponding glucose ureide hydrolase are the key substance and the key enzyme, respectively, of the enzymatic sugar ureide degradation process that is exclusively initiated by C. innocuum in the human caecum (Mohr et al., 1999; Wutzke and Glasenapp, 2004) . Our previous studies revealed that the application of 13 C-LU, 13 C-GU and 13 C-CU lead to significantly shorter OCTT data of 419 vs 311 (P ¼ 0.028), 415 vs 287 (P ¼ 0.017) and 401 vs 266 (P ¼ 0.012) min, respectively, when pre-dosing with the respective unlabelled ureides LU, GU and CU (Wutzke and Glasenapp, 2004; Wutzke and Schütt, 2007) . Therefore, we concluded that pre-dosing with the analogues substrate in its unlabelled form is essential for OCTT measurements to obtain reliable results. Furthermore, 15 N-LU has been additionally applied as a biomarker for studying colonic ammonia metabolism to assess the effects of pro-and pre-biotics on the intestinal flora in humans, and for measuring the transfer of 15 N (Jackson et al., 2004; De Preter et al., 2004; Geboes et al., 2005) . In this study, pre-dosing with GU and CU, both chemically different from the subsequent ingested DLLU, resulted in a faster increase of the initial 13 CO 2 output and correspondingly in a higher 13 C signal, thus, in comparison with the measured OCTT without pre-dosing (7.8 h), leading to reliable OCTT of 5.8 and 6.0 h, respectively. The increase of the 13 CO 2 -enrichment in the expired air reflected the microbial degradation of DLLU. These observations of an apparently shorter OCTT after pre-dosing with chemically different sugar ureides strongly suggest a preceding induction of the enzyme activity as already claimed earlier when pre-dosing with the same ureide in its unlabelled form (Wutzke et al., 1997; Wutzke and Glasenapp, 2004; Wutzke and Schütt, 2007) . Furthermore, it could be demonstrated that pre-dosing with merely 3 Â 120 mg GU as well as the equimolar dosage of 3 Â 200 mg CU is high enough to induce the enzyme activity and to give reliable results. In previously published papers, higher dosages of up to 5 Â 1 g LU have been used in adults (Morrison et al., 2003; Wutzke and Glasenapp, 2004) . The relatively low dosage of GU and CU, respectively, applied in this study minimize a potential influence of pre-dosing on OCTT. For this reason, a longer pre-dosing procedure would be counterproductive. Our measured data are in agreement with the OCTTs of 320, 292, 287 and 246 min published by Leitzmann et al. (1998); Geypens et al. (1999); Wutzke and Glasenapp (2004); and Wutzke and Sattinger (2006) , respectively, in healthy adults. The observed CPDR and CPE data were also in the same order of magnitude with the values published earlier (Wutzke and Glasenapp, 2004; Wutzke and Schütt, 2007) . In contrast to the measurement of the OCTT along with the mandatory pre-treatment procedure, our findings demonstrate that (except for the GU pre-dosing with a high s.d., presumably caused by an incomplete homogenization of the faeces) neither the urinary nor the faecal total CPE are affected by pre-dosing with both unlabelled ureides ( N-GU) are partially absorbed from the small bowel (Heine et al., 1995; Wutzke et al., 1997; Morrison et al., 2003) . After the bacterial degradation of the DLLU in the colon, the originated end products 13 Lactose-[
